RICCIO, ANNA
 Distribuzione geografica
Continente #
NA - Nord America 658
EU - Europa 150
AS - Asia 70
OC - Oceania 2
Totale 880
Nazione #
US - Stati Uniti d'America 656
IT - Italia 79
SG - Singapore 54
IE - Irlanda 31
RU - Federazione Russa 10
CZ - Repubblica Ceca 8
DE - Germania 5
KR - Corea 5
CH - Svizzera 4
CN - Cina 4
SE - Svezia 4
HK - Hong Kong 3
AU - Australia 2
FR - Francia 2
GB - Regno Unito 2
IN - India 2
MX - Messico 2
PL - Polonia 2
BG - Bulgaria 1
PK - Pakistan 1
RO - Romania 1
TW - Taiwan 1
UA - Ucraina 1
Totale 880
Città #
Wilmington 222
Houston 164
Chandler 61
Singapore 48
Rome 42
Dublin 28
Medford 21
Fairfield 15
Santa Clara 13
Seattle 11
Lawrence 10
Menlo Park 10
Milan 10
San Francisco 9
Brno 7
Woodbridge 7
Cambridge 5
Falls Church 5
Seoul 5
Ashburn 4
Cagliari 4
Ann Arbor 3
Dearborn 3
Munich 3
San Diego 3
Centrale 2
Ciampino 2
Dallas 2
Jupiter 2
Moscow 2
New York 2
Redwood City 2
Sydney 2
Torino 2
Vicenza 2
Brugherio 1
Civitavecchia 1
Constanta 1
Council Bluffs 1
East Hampton 1
Faisalabad 1
Guangzhou 1
Gunten 1
Hangzhou 1
Hounslow 1
Ivry-sur-seine 1
Jacksonville 1
Mumbai 1
Nanjing 1
Ningbo 1
Norwalk 1
Parma 1
Saint Petersburg 1
San Mateo 1
Sofia 1
Warsaw 1
Totale 754
Nome #
Role of AIRAP in the regulation of survival signaling in human melanoma 128
Nitazoxanide is an effective inhibitor of human rhinovirus replication in vitro 123
The biogenesis of SARS-CoV-2 spike glycoprotein: multiple targets for host-directed antiviral therapy 103
HSF1 and nucleolar stress: role of NKRF 90
Heat shock factors beyond stress 89
Role of HSF1 in proteasome regulation during proteotoxic stress 82
Synthesis of the 4-aza cyclopentenone analogue of Δ12,14-15-deoxy-PGJ2 and S-cysteine adducts 71
HSF1 and cancer cell survival: new actors on the scene 66
null 60
The proteostasis guardian HSF1 directs the transcription of its paralog and interactor HSF2 during proteasome dysfunction 59
Antiviral thiazolides inhibit paramyxovirus replication by targeting the Fusion protein folding: role of glycoprotein-specific disulfide isomerase ERp57 45
The FDA-approved drug nitazoxanide is a potent inhibitor of human seasonal coronaviruses acting at postentry level: effect on the viral spike glycoprotein 9
Indomethacin inhibits human seasonal coronaviruses at late stages of viral replication in lung cells: Impact on virus-induced COX-2 expression 5
Totale 930
Categoria #
all - tutte 3.569
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.569


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202064 0 0 0 0 1 2 1 1 0 0 0 59
2020/2021423 43 46 41 48 41 45 92 40 14 4 8 1
2021/202295 2 11 0 2 5 10 3 15 9 7 1 30
2022/2023166 15 7 10 12 28 37 11 19 19 1 7 0
2023/202454 10 3 4 3 5 2 9 6 2 4 0 6
2024/2025119 19 53 21 7 19 0 0 0 0 0 0 0
Totale 930